Hoth Therapeutics (HOTH) Q4 2024 Earnings

12NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.72
-0.56
-0.4
-0.24

Details

Expected EPS
-0.305
Actual EPS
-0.31
Surprise EPS
-0.01
Surprise Percent
+1.64%

Description

Hoth Therapeutics (HOTH) has reported earnings of -0.31 per share for Q4 2024.

0 Comments

Share your thoughts